NCT07251270 Effect of Stress Ball During Chest Tube Removal After Open Heart Surgery
| NCT ID | NCT07251270 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mersin University |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2025-11-27 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2025-11-27 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
15 minutes before the procedure, nurses (FEÖ and NT) will explain and demonstrate how to use the stress ball. The stress ball will be applied for approximately five minutes, including the chest tube removal procedure. A round, medium-hard, high-quality silicone ball, approximately 6 cm in diameter, will be used. Patients will be asked to hold the ball in their palms, count to three, squeeze, and release once. Patients will be instructed to continue this exercise until the chest tube removal procedure is completed, and then, under the supervision of the researcher, for approximately five minutes, focusing their attention on the stress ball. The ball will be washed and cleaned after each use and wiped with disposable asepsis wipes before being administered to the patient. The control group will not receive any other treatment beyond routine treatment and will be assessed at the same time as the study group. The chest tube will be removed by a physician during the stress ball application. Procedural pain level, anxiety level and hemodynamic variables of all patients in the study and control groups will be re-evaluated immediately after chest tube removal and 15 and 30 minutes after chest tube removal.
Eligibility Criteria
Inclusion Criteria:Patients will be included : have only one chest tube after open heart surgery, * are 18 years of age or older, * are conscious and cooperative, * speak and understand Turkish, * have a stable general condition and hemodynamic variables, * have a planned surgical procedure, * have no previous chest tube experience, * have no psychiatric diagnosis, * are not using psychiatric and/or local neuromuscular blocking medications, * agree to participate in the study (sign the Informed Consent Form). Exclusion Criteria:Patients who do not have a chest tube or have multiple chest tubes after open heart surgery, * Are under 18 years of age, * Are conscious and uncooperative, * Do not speak or understand Turkish, * Are in an unstable general condition or hemodynamic variables, * Have undergone emergency surgery, * Have previous chest tube placement experience, * Have a current psychiatric diagnosis, * Are taking psychiatric and/or local neuromuscular blocking medications, * Do not agree to participate in the study (do not sign the Informed Consent Form) will not be included in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07251270 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07251270 currently recruiting?
Yes, NCT07251270 is actively recruiting participants. Contact the research team at tugbacam@mersin.edu.tr for enrollment information.
Where is the NCT07251270 trial being conducted?
This trial is being conducted at Yenişehir, Turkey (Türkiye).
Who is sponsoring the NCT07251270 clinical trial?
NCT07251270 is sponsored by Mersin University. The trial plans to enroll 46 participants.